Formulation and Drug Delivery

FDA’s Office of New Drugs Highlights New Research Projects for Growth

April 18, 2023

Jaeger notes that the program is focused on addressing specific scientific questions that will produce immediate impacts on how CDER and FDA make drug approval decisions.

Nucleic Acid-based Therapeutics Are Stepping into the Spotlight

April 15, 2023

The recent success of mRNA vaccines has opened the door for further and future development of nucleic acid-based therapies.

Learning to Think at Lightspeed

April 15, 2023

Actions combatting the next pandemic must be diverse, reliable, and sustainable.

Managing mRNA Instability

April 15, 2023

Unique solutions are required to protect inherently unstable messenger RNA.

The Role of Separation Techniques in the Analysis of mRNA Therapeutic Drug Substances and Drug Products

April 15, 2023

This article reviews a range of techniques available for separative analysis of mRNA therapeutics, their associated impurities, and delivery vehicles.

The Marriage of RNA and Mass Spectrometry

April 15, 2023

Considerable efforts have been made over the years to resolve the key issues of stability and delivery of RNA-based therapeutics.

Delivering on the Potential of mRNA Therapeutics

April 15, 2023

The complexity of the RNA production process creates challenges.

Unpacking Precision Vaccines with Nicole Lewis (World Vaccine Conference 2023)

April 06, 2023

Nicole Lewis, PVP Program Manager at Boston Children's Hospital, discusses the science behind precision vaccines, a form of personalized vaccines.

Formulating Drugs for Continuous Processing

April 03, 2023

Despite the advantages intensified processes can offer developers, there are still some obstacles to overcome before broader application of new technologies will be implemented.

Accepting Alternative Approaches to Freeze Drying

April 02, 2023

Alternative approaches to freeze-drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.